Lasse Kervinen

Title: Lasse Kervinen: Innovator in Pharmaceutical Composition

Introduction

Lasse Kervinen is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 2 patents to his name, Kervinen's work is recognized for its innovative approach to medication formulation.

Latest Patents

Kervinen's latest patents include a pharmaceutical composition comprising entacapone, levodopa, and carbidopa. This oral solid fixed dose composition contains pharmacologically effective amounts of these compounds, or their pharmaceutically acceptable salts or hydrates, along with at least one pharmaceutically acceptable excipient. The composition is designed for the treatment of Parkinson's disease, showcasing Kervinen's commitment to improving patient care through innovative drug formulations.

Career Highlights

Kervinen is associated with Orion Corporation, a leading pharmaceutical company in Finland. His work at Orion has allowed him to focus on developing effective treatments for neurological conditions. His contributions have been instrumental in advancing the understanding and management of Parkinson's disease.

Collaborations

Kervinen has collaborated with esteemed colleagues such as Matti Virkki and Kari Vahervuo. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical sector.

Conclusion

Lasse Kervinen's work exemplifies the impact of innovation in the pharmaceutical industry. His patents reflect a dedication to improving treatments for Parkinson's disease, and his collaborations further strengthen the field of medical research.